Tag Intelligence
Insights derived from canonical tags and inferred domains across recent documents.
Topic Lanes (Domains)
Rising Tags
- alzheimer's disease — +2 (2 in last 20)
- biomarkers — +2 (3 in last 20)
- clinical trial — +2 (2 in last 20)
- fibrosis — +2 (4 in last 20)
- mash — +2 (5 in last 20)
- metabolic liver disease — +2 (2 in last 20)
- oncology — +2 (2 in last 20)
- type 2 diabetes — +2 (2 in last 20)
- accelerated approval — +1 (1 in last 20)
- acute liver failure — +1 (1 in last 20)
- alcohol-related liver disease — +1 (1 in last 20)
- aml — +1 (1 in last 20)
- antigen stimulation — +1 (1 in last 20)
- antimicrobial plastics — +1 (1 in last 20)
- apoe4 — +1 (1 in last 20)
Co-occurring Tag Pairs
- mash + metabolic liver disease — 2
- mash + rezdiffra (resmetirom — 2
- alzheimer's disease + blood sugar control — 1
- alzheimer's disease + dementia risk — 1
- alzheimer's disease + hba1c stability — 1
- alzheimer's disease + personalized medicine — 1
- alzheimer's disease + type 2 diabetes — 1
- blood sugar control + dementia risk — 1
- blood sugar control + hba1c stability — 1
- blood sugar control + personalized medicine — 1
- blood sugar control + type 2 diabetes — 1
- dementia risk + hba1c stability — 1
- dementia risk + personalized medicine — 1
- dementia risk + type 2 diabetes — 1
- hba1c stability + personalized medicine — 1
Bridge Tags (Cross-Domain)
- clinical trial — 3 domains
- commercial strategy — 3 domains
- drug development — 3 domains
- liver disease — 3 domains
- mash — 3 domains
- nash — 3 domains
- biomarkers — 2 domains
- cirrhosis — 2 domains
- combination therapy — 2 domains
- ervogastat — 2 domains
- fibrosis — 2 domains
- gene silencing — 2 domains
- macrophages — 2 domains
- madrigal pharmaceuticals — 2 domains
- medical affairs — 2 domains